Pyridoxine administration improves behavioral and anatomical outcome after unilateral contusion injury in the rat

Nicholas J. Kuypers, Michael R. Hoane

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The purpose of this project was to evaluate the preclinical efficacy of pyridoxine, or vitamin B6. Rats received a 3.0mm unilateral controlled cortical impact (CCI) injury of the sensorimotor cortex or sham surgery. Treatment with vitamin B6 (600 or 300mg/kg IP) or vehicle was administered at 30min and 24h post-CCI. Somatosensory dysfunction was evaluated with the vibrissae-forelimb placing and bilateral tactile adhesive removal tests. Sensorimotor dysfunction was evaluated with the locomotor placing and the forelimb asymmetry tests. On the forelimb asymmetry test both treatment groups displayed no asymmetry bias on any of the testing days post-CCI and were statistically no different than the shams. Both vitamin B6 groups displayed a significant improvement in behavioral performance on the locomotor placing test compared to the vehicle-treated group. Administration of 600mg/kg also significantly reduced tactile adhesive removal latencies on days 2, 4, 6, and 12 post-CCI. Both treatment groups were improved in their rate of recovery post-CCI on the vibrissae-forelimb placing test, but only the recovery seen in the 600-mg/kg group was significantly improved compared to vehicle. Finally, the 600-mg/kg dose resulted in significant cortical sparing compared to the vehicle-treated group. In general, the effects of vitamin B6 on recovery of function were dose-dependent, with the 600-mg/kg dose consistently showing greater recovery than the 300-mg/kg dose. More experimental analyses are warranted to evaluate the potential preclinical efficacy and mechanistic action of vitamin B6.

Original languageEnglish (US)
Pages (from-to)1275-1282
Number of pages8
JournalJournal of Neurotrauma
Volume27
Issue number7
DOIs
StatePublished - Jul 1 2010
Externally publishedYes

Fingerprint

Pyridoxine
Vitamin B 6
Contusions
Forelimb
Wounds and Injuries
Vibrissae
Touch
Adhesives
Recovery of Function

Keywords

  • B-vitamin
  • controlled cortical impact
  • recovery of function
  • traumatic brain injury
  • treatment
  • vitamin B
  • vitanutrient

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Pyridoxine administration improves behavioral and anatomical outcome after unilateral contusion injury in the rat. / Kuypers, Nicholas J.; Hoane, Michael R.

In: Journal of Neurotrauma, Vol. 27, No. 7, 01.07.2010, p. 1275-1282.

Research output: Contribution to journalArticle

@article{6f6bb194281c44299ca5ab9157a5628b,
title = "Pyridoxine administration improves behavioral and anatomical outcome after unilateral contusion injury in the rat",
abstract = "The purpose of this project was to evaluate the preclinical efficacy of pyridoxine, or vitamin B6. Rats received a 3.0mm unilateral controlled cortical impact (CCI) injury of the sensorimotor cortex or sham surgery. Treatment with vitamin B6 (600 or 300mg/kg IP) or vehicle was administered at 30min and 24h post-CCI. Somatosensory dysfunction was evaluated with the vibrissae-forelimb placing and bilateral tactile adhesive removal tests. Sensorimotor dysfunction was evaluated with the locomotor placing and the forelimb asymmetry tests. On the forelimb asymmetry test both treatment groups displayed no asymmetry bias on any of the testing days post-CCI and were statistically no different than the shams. Both vitamin B6 groups displayed a significant improvement in behavioral performance on the locomotor placing test compared to the vehicle-treated group. Administration of 600mg/kg also significantly reduced tactile adhesive removal latencies on days 2, 4, 6, and 12 post-CCI. Both treatment groups were improved in their rate of recovery post-CCI on the vibrissae-forelimb placing test, but only the recovery seen in the 600-mg/kg group was significantly improved compared to vehicle. Finally, the 600-mg/kg dose resulted in significant cortical sparing compared to the vehicle-treated group. In general, the effects of vitamin B6 on recovery of function were dose-dependent, with the 600-mg/kg dose consistently showing greater recovery than the 300-mg/kg dose. More experimental analyses are warranted to evaluate the potential preclinical efficacy and mechanistic action of vitamin B6.",
keywords = "B-vitamin, controlled cortical impact, recovery of function, traumatic brain injury, treatment, vitamin B, vitanutrient",
author = "Kuypers, {Nicholas J.} and Hoane, {Michael R.}",
year = "2010",
month = "7",
day = "1",
doi = "10.1089/neu.2010.1327",
language = "English (US)",
volume = "27",
pages = "1275--1282",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "7",

}

TY - JOUR

T1 - Pyridoxine administration improves behavioral and anatomical outcome after unilateral contusion injury in the rat

AU - Kuypers, Nicholas J.

AU - Hoane, Michael R.

PY - 2010/7/1

Y1 - 2010/7/1

N2 - The purpose of this project was to evaluate the preclinical efficacy of pyridoxine, or vitamin B6. Rats received a 3.0mm unilateral controlled cortical impact (CCI) injury of the sensorimotor cortex or sham surgery. Treatment with vitamin B6 (600 or 300mg/kg IP) or vehicle was administered at 30min and 24h post-CCI. Somatosensory dysfunction was evaluated with the vibrissae-forelimb placing and bilateral tactile adhesive removal tests. Sensorimotor dysfunction was evaluated with the locomotor placing and the forelimb asymmetry tests. On the forelimb asymmetry test both treatment groups displayed no asymmetry bias on any of the testing days post-CCI and were statistically no different than the shams. Both vitamin B6 groups displayed a significant improvement in behavioral performance on the locomotor placing test compared to the vehicle-treated group. Administration of 600mg/kg also significantly reduced tactile adhesive removal latencies on days 2, 4, 6, and 12 post-CCI. Both treatment groups were improved in their rate of recovery post-CCI on the vibrissae-forelimb placing test, but only the recovery seen in the 600-mg/kg group was significantly improved compared to vehicle. Finally, the 600-mg/kg dose resulted in significant cortical sparing compared to the vehicle-treated group. In general, the effects of vitamin B6 on recovery of function were dose-dependent, with the 600-mg/kg dose consistently showing greater recovery than the 300-mg/kg dose. More experimental analyses are warranted to evaluate the potential preclinical efficacy and mechanistic action of vitamin B6.

AB - The purpose of this project was to evaluate the preclinical efficacy of pyridoxine, or vitamin B6. Rats received a 3.0mm unilateral controlled cortical impact (CCI) injury of the sensorimotor cortex or sham surgery. Treatment with vitamin B6 (600 or 300mg/kg IP) or vehicle was administered at 30min and 24h post-CCI. Somatosensory dysfunction was evaluated with the vibrissae-forelimb placing and bilateral tactile adhesive removal tests. Sensorimotor dysfunction was evaluated with the locomotor placing and the forelimb asymmetry tests. On the forelimb asymmetry test both treatment groups displayed no asymmetry bias on any of the testing days post-CCI and were statistically no different than the shams. Both vitamin B6 groups displayed a significant improvement in behavioral performance on the locomotor placing test compared to the vehicle-treated group. Administration of 600mg/kg also significantly reduced tactile adhesive removal latencies on days 2, 4, 6, and 12 post-CCI. Both treatment groups were improved in their rate of recovery post-CCI on the vibrissae-forelimb placing test, but only the recovery seen in the 600-mg/kg group was significantly improved compared to vehicle. Finally, the 600-mg/kg dose resulted in significant cortical sparing compared to the vehicle-treated group. In general, the effects of vitamin B6 on recovery of function were dose-dependent, with the 600-mg/kg dose consistently showing greater recovery than the 300-mg/kg dose. More experimental analyses are warranted to evaluate the potential preclinical efficacy and mechanistic action of vitamin B6.

KW - B-vitamin

KW - controlled cortical impact

KW - recovery of function

KW - traumatic brain injury

KW - treatment

KW - vitamin B

KW - vitanutrient

UR - http://www.scopus.com/inward/record.url?scp=77955075524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955075524&partnerID=8YFLogxK

U2 - 10.1089/neu.2010.1327

DO - 10.1089/neu.2010.1327

M3 - Article

VL - 27

SP - 1275

EP - 1282

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 7

ER -